Detail page

Knowledge Web

Person

Constantin Frederik Victor Lapa (1982-)

Radiologe

Name	Constantin Frederik Victor Lapa
Time	1982- (Date of birth and death)
Place	Münster (Westf) (Geburtsort) Deutschland
Academic degree	Dr. med. habil.
Profession	Radiologe (characteristic profession)
Variant	Constantin Lapa (Metadaten)
Related	Universitätsklinikum Augsburg
Further information	Diss. Ludwig-Maximilians-Universität München, Medizinische Fakultät; Habilitation an der Medizinischen Fakultät für das Fach Nuklearmedizin der Uni Würzburg (2016); Direktor der Klinik für Nuklearmedizin am Universitätsklinikum Augsburg
Source	Vorlage, www: https://www.researchgate.net/profile/Constantin_Lapa (Stand: 19.09.2017)
Record type	Person
GND-Identifier	1011355892
Record ID	1011355892
Involved in show all FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study Gastrointestinal Neuroendocrine Neoplasms in Children and Adolescents: Data from the German MET Studies (1997–2024) [99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery Gastroenteropancreatic neuroendocrine neoplasms in children and adults: a comparative review Gastrointestinal neuroendocrine neoplasms in children and adolescents: data from the German MET studies (1997-2024) Machine learning prediction of recurrence in pediatric thyroid cancer: malignant endocrine tumors cohort analysis using XGBoost and SHAP SSTR-directed radiopharmaceutical therapy in a patient with small cell lung cancer: an intrapatient comparison of SSTR-agonist and antagonist [99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family PET imaging utilization and trends in Germany: a comprehensive survey Neue Ansätze in der Nuklearmedizinischen Diagnostik und Therapie Cardiac risk in recovered Covid-19 patients evaluated by 123I-mIBG CCK2 receptor ligand [68Ga]Ga-DOTA-CCK-66 PET/CT outperforms [68Ga]Ga-DOTATOC PET/CT in a patient with small cell lung cancer Comprehensive characterization via molecular imaging, longitudinal multisite sampling, and autoptic work-up in advanced small cell lung cancer undergoing SSTR-directed radiopharmaceutical therapy Current insights and future directions in systemic therapies for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) in children and adolescents: a critical review of advancements and challenges Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinity European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T Feasibility of short-term redifferentiation in patients with radioactive iodine–refractory metastatic thyroid cancer Impact of regularization in optimizing distance-encoding biomorphic-informational neural networks for small nuclear medicine datasets Intense FAP expression of ovarian metastatic breast cancer detected by [68Ga]RTX-1363 PET/CT [Image abstract] Interpretable machine learning for thyroid cancer recurrence predicton: leveraging XGBoost and SHAP analysis Invisible origins: paediatric neuroendocrine neoplasms of unknown primary site in the MET Registry and SEER database Myeloablative radioligand therapy targeting C-X-C motif chemokine receptor 4 in advanced multiple myeloma Noninvasive characterization of hepatic lesions by means of glypican-3–directed PET/CT Optimisation of αvβ6 and αvβ8 Integrin Targeting Radiopharmaceuticals: Preclinical Research to Clinical Translation Utilising Multimerisation as a Strategy for Drug Development Pancreatic neuroendocrine tumors in children and adolescents - data from the German MET studies (1997–2023) PET imaging utilization and trends in Germany: a comprehensive survey Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for targeted alpha therapy Redefining AT1 receptor PET imaging: introducing the radiotracer [18F]DR29 Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma Die moderne TARE 2023 – von der Palliativversorgung zur kurativen Behandlungsalternative Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) – a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients [18F]FDG PET/CT imaging is associated with lower in-hospital mortality in patients with pyogenic spondylodiscitis — a registry-based analysis of 29,362 cases [68Ga]Ga-RAYZ-8009: a glypican-3–targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging — a first-in-human case series 18fluorodeoxyglucose PET/CT as possible early diagnostic tool preceding MRI changes in Borna disease virus 1 encephalitis Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity Biodistribution and dosimetry of the CCK2R ligand [68Ga]Ga-DOTA-CCK-66: first clinical results [Abstract] Biodistribution and radiation dosimetry for 68Ga-DOTA-CCK-66, a novel CCK2R-targeting compound for imaging of medullary thyroid cancer Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer C-X-C motif chemokine receptor 4–directed scintigraphy of multiple myeloma using [99mTc]Tc-PentixaTec C-X-C motif chemokine receptor 4–directed scintigraphy using [99mTc]Tc-pentixatec in primary aldosteronism: a proof-of-concept study CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66 Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) - a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors — a comprehensive analysis of imaging findings and comparison with histopathology CXCR4-directed SPECT imaging using [99mTc]Tc-PentixaTec in patients with primary aldosteronism [Abstract] CXCR4-targeted theranostics in hematooncology: opportunities and challenges CXCR4-targeted theranostics in hematooncology: opportunities and challenges = CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen Determinants of the need for psycho-oncological treatment using the Hornheider Screening Instrument in thyroid cancer patients [Abstract] Diagnostische Methoden in der Kardiologie: Bildgebung und apparative Untersuchung Die moderne TARE 2023 - von der Palliativversorgung zur kurativen Behandlungsalternative Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders

Please note

The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link:

Katalog der Deutschen Nationalbibliothek

Constantin Frederik Victor Lapa (1982-)

FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study

Gastrointestinal Neuroendocrine Neoplasms in Children and Adolescents: Data from the German MET Studies (1997–2024)

[99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family

FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study

FAPi-PET/CT as surrogate marker for subclinical myocardial fibrosis is a prognostic tool for patients undergoing left-sided heart valve surgery

Gastroenteropancreatic neuroendocrine neoplasms in children and adults: a comparative review

Gastrointestinal neuroendocrine neoplasms in children and adolescents: data from the German MET studies (1997-2024)

Machine learning prediction of recurrence in pediatric thyroid cancer: malignant endocrine tumors cohort analysis using XGBoost and SHAP

SSTR-directed radiopharmaceutical therapy in a patient with small cell lung cancer: an intrapatient comparison of SSTR-agonist and antagonist

[99mTc]Tc-PSMA-HSG for PSMA-targeted Hybrid Surgical Guidance: a new addition to the PSMA-I&S/I&T family

PET imaging utilization and trends in Germany: a comprehensive survey

Neue Ansätze in der Nuklearmedizinischen Diagnostik und Therapie

Cardiac risk in recovered Covid-19 patients evaluated by 123I-mIBG

CCK2 receptor ligand [68Ga]Ga-DOTA-CCK-66 PET/CT outperforms [68Ga]Ga-DOTATOC PET/CT in a patient with small cell lung cancer

Comprehensive characterization via molecular imaging, longitudinal multisite sampling, and autoptic work-up in advanced small cell lung cancer undergoing SSTR-directed radiopharmaceutical therapy

Current insights and future directions in systemic therapies for gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) in children and adolescents: a critical review of advancements and challenges

Deciphering the structural impact of norepinephrine analog radiopharmaceuticals on organic cation transporter affinity

European clinical guidance for the management of adrenal and extra-adrenal paraganglioma in children and adolescents: a consensus by the EXPeRT group

Experience of rescue therapy with [177Lu]Lu-rhPSMA-10.1 in patients with primary or acquired resistance to [177Lu]Lu-PSMA-I&T

Feasibility of short-term redifferentiation in patients with radioactive iodine–refractory metastatic thyroid cancer

Impact of regularization in optimizing distance-encoding biomorphic-informational neural networks for small nuclear medicine datasets

Intense FAP expression of ovarian metastatic breast cancer detected by [68Ga]RTX-1363 PET/CT [Image abstract]

Interpretable machine learning for thyroid cancer recurrence predicton: leveraging XGBoost and SHAP analysis

Invisible origins: paediatric neuroendocrine neoplasms of unknown primary site in the MET Registry and SEER database

Myeloablative radioligand therapy targeting C-X-C motif chemokine receptor 4 in advanced multiple myeloma

Noninvasive characterization of hepatic lesions by means of glypican-3–directed PET/CT

Optimisation of αvβ6 and αvβ8 Integrin Targeting Radiopharmaceuticals: Preclinical Research to Clinical Translation Utilising Multimerisation as a Strategy for Drug Development

Pancreatic neuroendocrine tumors in children and adolescents - data from the German MET studies (1997–2023)

PET imaging utilization and trends in Germany: a comprehensive survey

Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for targeted alpha therapy

Redefining AT1 receptor PET imaging: introducing the radiotracer [18F]DR29

Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma

Value of PET radiomic features for diagnosis and reccurence prediction of newly diagnosed oral squamous cell carcinoma

Preclinical evaluation of 225Ac-labeled minigastrin analog DOTA-CCK-66 for Targeted Alpha Therapy

EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders

Interobserver Agreement Rates on CXCR4-Directed PET/CT in Patients with Marginal Zone Lymphoma

Die moderne TARE 2023 – von der Palliativversorgung zur kurativen Behandlungsalternative

Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia

CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges

Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) – a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients

[18F]FDG PET/CT imaging is associated with lower in-hospital mortality in patients with pyogenic spondylodiscitis — a registry-based analysis of 29,362 cases

[68Ga]Ga-RAYZ-8009: a glypican-3–targeted diagnostic radiopharmaceutical for hepatocellular carcinoma molecular imaging — a first-in-human case series

18fluorodeoxyglucose PET/CT as possible early diagnostic tool preceding MRI changes in Borna disease virus 1 encephalitis

Accuracy of 18-F Fluorodeoxyglucose Positron Emission Tomographic/Computed Tomographic Imaging in Primary Staging of Squamous Cell Carcinoma of the Oral Cavity

Biodistribution and dosimetry of the CCK2R ligand [68Ga]Ga-DOTA-CCK-66: first clinical results [Abstract]

Biodistribution and radiation dosimetry for 68Ga-DOTA-CCK-66, a novel CCK2R-targeting compound for imaging of medullary thyroid cancer

Biodistribution and radiation dosimetry of [99mTc]Tc-N4-BTG in patients with biochemical recurrence of prostate cancer

C-X-C motif chemokine receptor 4–directed scintigraphy of multiple myeloma using [99mTc]Tc-PentixaTec

C-X-C motif chemokine receptor 4–directed scintigraphy using [99mTc]Tc-pentixatec in primary aldosteronism: a proof-of-concept study

CCK2 receptor–targeted PET/CT in medullary thyroid cancer using [68Ga]Ga-DOTA-CCK-66

Concept and feasibility of the Augsburg Longitudinal Plasma Study (ALPS) - a prospective trial for comprehensive liquid biopsy-based longitudinal monitoring of solid cancer patients

CXCR4-directed PET/CT with [68 Ga]Ga-pentixafor in solid tumors — a comprehensive analysis of imaging findings and comparison with histopathology

CXCR4-directed SPECT imaging using [99mTc]Tc-PentixaTec in patients with primary aldosteronism [Abstract]

CXCR4-targeted theranostics in hematooncology: opportunities and challenges

CXCR4-targeted theranostics in hematooncology: opportunities and challenges = CXCR4-gerichtete Theranostics in der Hämato-Onkologie: Möglichkeiten und Herausforderungen

Determinants of the need for psycho-oncological treatment using the Hornheider Screening Instrument in thyroid cancer patients [Abstract]

Diagnostische Methoden in der Kardiologie: Bildgebung und apparative Untersuchung

Die moderne TARE 2023 - von der Palliativversorgung zur kurativen Behandlungsalternative

Disclosing tumor biology by means of molecular imaging in a patient with malignant melanoma and chronic lymphocytic leukemia

EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders